# A Safety and Efficacy Study of Hymecromone Tablets for the Treatment of Patients With COVID-19.

> **NCT05386420** · NA · UNKNOWN · sponsor: **Shanghai Zhongshan Hospital** · enrollment: 304 (estimated)

## Conditions studied

- COVID-19

## Interventions

- **DRUG:** Hymecromone tablets
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT05386420
- **Lead sponsor:** Shanghai Zhongshan Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2022-05-23
- **Primary completion:** 2022-08-15
- **Final completion:** 2022-11-15
- **Target enrollment:** 304 (ESTIMATED)
- **Last updated:** 2022-06-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05386420

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05386420, "A Safety and Efficacy Study of Hymecromone Tablets for the Treatment of Patients With COVID-19.". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT05386420. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*